Keeping Track: FDA Approves Adlyxin, Accepts Brineura, Lowers Hurdle For Xadago

The latest drug development news and highlights from our FDA Performance Tracker.

This week, FDA's Center for Drug Evaluation and Research made Sanofi's Adlyxin (lixisenatide) the 16th novel agent approved in 2016.

The agency also continued to issue complete response letters at a steady clip. Another eye drug received a CRL citing...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America